Stefan Pöhlmann Selected Research

Stefan Pöhlmann Research Topics

Disease

73	Infections 04/2024 - 04/2002
47	COVID-19 04/2024 - 01/2020
19	Virus Diseases (Viral Diseases) 03/2024 - 11/2004
12	Vesicular Stomatitis 03/2024 - 06/2004
7	Human Influenza (Influenza) 01/2022 - 07/2009
5	Severe Acute Respiratory Syndrome 01/2022 - 06/2004
5	Ebola Hemorrhagic Fever 04/2021 - 08/2002
4	Coronavirus Infections 01/2023 - 09/2014
3	Lung Injury 01/2022 - 01/2010
3	Inflammation (Inflammations) 01/2022 - 01/2021
3	Filoviridae Infections 01/2019 - 11/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 01/2006
2	Breakthrough Infections 11/2022 - 11/2022
2	Hemorrhage 01/2022 - 11/2021
2	Critical Illness (Critically Ill) 12/2021 - 01/2021
2	Neoplasms (Cancer) 01/2019 - 07/2009
2	Fever (Fevers) 04/2013 - 11/2011
1	Convalescence 04/2024
1	Fatigue 02/2024
1	RNA Virus Infections 10/2022
1	Fibrosarcoma 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Hypoxia (Hypoxemia) 12/2021
1	Lymphopenia (Lymphocytopenia) 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021

Drug/Important Bio-Agent (IBA)

28	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2011
26	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2004
17	AntibodiesIBA 04/2024 - 06/2004
17	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 01/2006
15	VaccinesIBA 11/2022 - 05/2005
15	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2020 - 08/2002
14	Glycoproteins (Glycoprotein)IBA 01/2024 - 09/2002
9	Neutralizing AntibodiesIBA 11/2022 - 06/2004
8	Serine Proteases (Serine Protease)IBA 01/2023 - 07/2009
7	InterferonsIBA 01/2023 - 01/2017
7	LectinsIBA 10/2020 - 08/2002
6	camostatIBA 01/2022 - 04/2015
6	Bone Marrow Stromal Antigen 2IBA 01/2019 - 11/2011
5	BNT162 VaccineIBA 11/2022 - 01/2021
5	SARS-CoV-2 spike proteinIBA 01/2022 - 11/2020
4	Messenger RNA (mRNA)IBA 04/2024 - 01/2021
4	Monoclonal AntibodiesIBA 03/2024 - 10/2021
4	bamlanivimabIBA 01/2022 - 01/2021
4	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021 - 11/2020
4	Polysaccharides (Glycans)IBA 10/2020 - 01/2008
4	C-Type Lectins (C-Type Lectin)IBA 07/2011 - 01/2003
3	Angiotensin-Converting Enzyme 2IBA 01/2023 - 07/2004
3	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 10/2022
3	AcidsIBA 01/2021 - 11/2020
3	CeramidesIBA 01/2021 - 11/2020
3	EnzymesIBA 11/2020 - 12/2011
3	Sialic AcidsIBA 01/2018 - 10/2010
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 10/2022
2	dalbavancinIBA 09/2022 - 01/2021
2	CytokinesIBA 01/2022 - 10/2011
2	AntioxidantsIBA 01/2022 - 11/2021
2	Amino Acids FDA Link 01/2022 - 09/2006
2	Cysteamine (Mercaptamine)FDA Link 01/2022 - 11/2021
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 11/2021
2	sphingosine kinaseIBA 12/2021 - 04/2021
2	Ac-GQFR-kbtIBA 10/2021 - 05/2021
2	3,5-diisopropylsalicylic acid (DIPS)IBA 10/2021 - 01/2021
2	nafamostatIBA 10/2021 - 01/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2021 - 08/2020
2	Amitriptyline (Elavil)FDA LinkGeneric 01/2021 - 11/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 11/2020
2	LigandsIBA 01/2021 - 01/2017
2	AntigensIBA 11/2020 - 03/2020
2	CarbohydratesIBA 10/2020 - 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 04/2024
1	EpitopesIBA 06/2023
1	Fondaparinux (Arixtra)FDA Link 01/2023
1	AntithrombinsIBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	AnticoagulantsIBA 01/2023
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2023
1	COVID-19 VaccinesIBA 11/2022
1	molnupiravirIBA 10/2022
1	cilgavimabIBA 10/2022
1	sotrovimabIBA 10/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acidIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	PeptidomimeticsIBA 01/2022
1	pol Gene ProductsIBA 01/2022
1	imdevimabIBA 01/2022
1	AerosolsIBA 01/2022
1	LipidsIBA 12/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2021
1	HDL LipoproteinsIBA 12/2021
1	LyasesIBA 12/2021
1	Serum AlbuminIBA 12/2021
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	otamixabanIBA 10/2021

Therapy/Procedure

15	Therapeutics 01/2023 - 08/2002